Skip to main content
Fig. 1 | BMC Research Notes

Fig. 1

From: TRIM3 and TRIM16 as potential tumor suppressors in breast cancer patients

Fig. 1

Relative gene expression of TRIM3 (Tripartite-motif-3) in breast cancer samples compared with normal breast tissues and evaluation of relative gene expression of TRIM3 in 3 different clinical and pathological parameters through Real-time PCR. A The expression of the TRIM3 gene was significantly decreased in breast cancer tissues. B Relative gene expression of TRIM3 was evaluated in different grades of breast cancer. C Relative expression of TRIM3 was compared between the lymphatic/vascular invasive group and the non-invasive group. D Relative expression of TRIM3 was compared between perineural invasive group and non-invasive group. *p < 0.05, ***p < 0.001, ****p < 0.0001 significantly different from normal group. #p < 0.05, ##< 0.01 significantly different from the selected group

Back to article page